In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Need help?

Read the Frequently Asked Questions for a better use

Read more

 

Refine your search
Sponsor

ESC Congress 365

All ESC Congress resources in one online library

View thousands of videos, slides, abstracts and reports from the world's largest cardiovascular congress – anytime!

Any question or suggestion? Check the Frequently Asked Questions or send it to us by email.

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found.

SPONSORED RESOURCES

Presentations below are part of sessions supported by Boehringer Ingelheim.

Boehringer Ingelheim
Abstract Slides/e-posters Video Report ESC TV Interview
 
Panel discussion Q&A - RE-DUAL PCI and reversal: improving care decisions after coronary revascularisation.
Presenter: C P Cannon (Boston,US)
2017
more
 
Periprocedural oral anticoagulant use: an evolving field.
Presenter: G Y H Lip (Birmingham,GB)
2017
more
 
RE-CIRCUIT and reversal: how is our practice changing?
Presenter: H Calkins (Baltimore,US)
2017
more
 
Redefining anticoagulation in AF ablation: RE-CIRCUIT and RE-VERSE AD.
Presenter: R Schilling (London,GB), H Calkins (Baltimore,US)
2017
more
 
Rewire your thinking on AF ablation: impact of uninterrupted dabigatran.
Presenter: H Calkins (Baltimore,US), S Willems (Hamburg,DE)
2017
more
 
Safety, efficacy, control: choosing the right oral anticoagulant for our patients.
Presenter: T Villines (Rockville,US)
2017
more
 
Uninterrupted dabigatran in AF ablation: the RE-CIRCUIT trial.
Presenter: S Willems (Hamburg,DE)
2017
more
 
What does the future hold for patients on oral anticoagulants?
Presenter: J Halperin (New York,US)
2017
more
 
A specific reversal agent for dabigatran is available: should you have it in your electrophysiology lab?
Presenter: H Calkins (Baltimore,US), R Deo (Philadelphia,US)
2016
more
 
Anticoagulation 3.0: the first NOAC with a reversal agent.
Presenter: J Weitz (Hamilton,CA)
2016
more

The scientific programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

Boehringer Ingelheim